GeneSight Mental Health Monitor Media Kit

The GeneSight Mental Health Monitor is a nationwide survey conducted online by ACUPOLL Precision Research, Inc. between February 16-21, 2024 among a representative sample (n=1000) of U.S. adults age 18+. The margin of error in survey results for the total base population at a 95% confidence interval is +/- 3%. A nationally representative sample of adults aged 18 years or older was recruited and balanced to match U.S. Census quotas across five primary metrics (i.e., age, gender, income, region, ethnicity).

In addition to the nationally representative sample, a statistically reliable sample was desired of respondents who were self-reported as being diagnosed by a medical professional with depression or anxiety. The study also used mental health screening instruments, the Patient Health Questionnaire-2 (PHQ-2) for depression, and the General Anxiety Disorder (GAD-2) for anxiety, to better understand this population.

ACUPOLL has more than 30 years of experience conducting statistically valid research through careful recruiting and quality control measures.

Previous releases

93% of Adults who Identify as LGBTQ+ Have Used Coping Mechanisms or Addictive Behaviors to Manage their Mental Health, according to Myriad Genetics Nationwide Survey

Nearly twice as many LGBTQ+ respondents say they are currently diagnosed with depression and/or anxiety than the general population.

Is “Manning Up” Bringing Men Down?

Men are less likely to have a trusted mental healthcare provider than females.

77% of Americans have used addictive behaviors or unhealthy coping mechanisms to manage their mental health, according to Myriad Genetics nationwide survey

Medication failure leads 45% of respondents with depression and/or anxiety to turn to unhealthy coping mechanism

GeneSight Mental Health Monitor Reveals Gap on the Front Line of Mental Health Care

Survey finds primary care providers wish patients would raise mental health concerns so they can provide better overall care.

graphic of drawing of woman doctor with text “67% of women diagnosed wished their doctor had told them about genetic testing for medication outcomes”

2 Out of 3 Women With Depression or Anxiety Say They’ve Reached Their “Breaking Point,” Yet More than Half Wait a Year Before Seeking Treatment

Six in 10 of the women surveyed with depression or anxiety diagnosis say they have been ignored or dismissed by family, friends, and/or partners about their mental health concerns

New Year’s Resolutions: Americans Say Body & Mind Equally Important in Theory but Not in Practice, According to GeneSight® Mental Health Monitor Nationwide Survey

Now is the time when people start to think of new year’s resolutions to improve their health. For many, the focus is on physical goals like losing weight or exercising more. A nationwide survey suggests that many may want to consider adding mental health resolutions to their list.

The New Generation Gap: Nationwide Survey Finds Different Perspectives on Anxiety Between Parents, Young Adults

GeneSight Mental Health Monitor finds many parents struggle to know the difference between teenage behavior and a mental health challenge

One of the biggest issues parents of teenagers may face is determining if their child is
experiencing a mental health challenge or ordinary “growing pains.”

Americans’ anxiety impacted by the ongoing pandemic, yet 1 in 5 say they won’t seek treatment according to the GeneSight® Mental Health Monitor nationwide survey

Many Americans are experiencing anxiety symptoms as a result of the pandemic. Yet, one in five say they won’t seek treatment for mental health conditions and others say they won’t get help until these symptoms take a toll in their lives.

Only 8% of people remain hopeful after depression medication fails them, according to GeneSight® Mental Health Monitor nationwide survey

Depression medication trial and error is far too common – and may result in additional
mental health challenges.

New research reveals most Americans can’t identify the symptoms of depression

GeneSight® Mental Health Monitor finds large gap between what Americans think and what they actually know about recognizing depression

Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine,
today announced results from a recent nationwide poll, the GeneSight® Mental Health Monitor.

Depression Disconnect: GeneSight® Mental Health Monitor Shows Misunderstanding of Depression and Treatment

New poll shows 83% of people with depression agree life would be easier if others could understand their depression

In a new nationwide poll, the GeneSight® Mental Health Monitorfound that 83% of people with depression agree that life would be easier if others could understand their depression. Yet, most people who have not experienced depression may not be able to understand the challenges, including its treatment.

Experiencing Depression

To help others understand how depression feels, click on the thumbnail below to visit a virtual experience.

Dark messy bedroom representing how depression feels